Institute of Pharmacy, University of Regensburg, Universitätsstraße 31, 93053, Regensburg, Germany.
Sci Rep. 2020 Aug 6;10(1):13288. doi: 10.1038/s41598-020-70332-3.
Fluorescence/luminescence-based techniques play an increasingly important role in the development of test systems for the characterization of future drug candidates, especially in terms of receptor binding in the field of G protein-coupled receptors (GPCRs). In this article, we present the establishment of a homogeneous live cell-based BRET binding assay for the histamine H receptor with different fluorescently labeled squaramide-type compounds synthesized in the course of this study. Py-1-labeled ligand 8 (UR-KAT478) was found to be most suitable in BRET saturation binding experiments with respect to receptor affinity (pK = 7.35) and signal intensity. Real-time kinetic experiments showed a full association of 8 within approximately 30 min and a slow dissociation of the ligand from the receptor. Investigation of reference compounds in BRET-based competition binding with 8 yielded pK values in agreement with radioligand binding data. This study shows that the BRET binding assay is a versatile test system for the characterization of putative new ligands at the histamine H receptor and represents a valuable fluorescence-based alternative to canonical binding assays.
荧光/发光技术在开发未来药物候选物的测试系统方面发挥着越来越重要的作用,特别是在 G 蛋白偶联受体 (GPCR) 领域的受体结合方面。在本文中,我们介绍了使用在本研究过程中合成的不同荧光标记的 squaramide 型化合物建立基于活细胞的均相 BRET 结合测定法用于组胺 H 受体。在 BRET 饱和结合实验中,相对于受体亲和力 (pK = 7.35) 和信号强度,Py-1 标记的配体 8 (UR-KAT478) 被发现是最适合的。实时动力学实验表明,8 在大约 30 分钟内完全结合,并且配体从受体缓慢解离。用 8 进行基于 BRET 的竞争结合的参考化合物的研究得出的 pK 值与放射性配体结合数据一致。这项研究表明,BRET 结合测定法是一种用于表征组胺 H 受体的新型配体的多功能测试系统,是对经典结合测定法的有价值的荧光替代方法。